How to buy The Chemours Company stock

The Chemours Company is a specialty chemicals business based in the US. The Chemours Company shares (CC) are listed on the NYSE and all prices are listed in US Dollars. The Chemours Company employs 7,000 staff and has a trailing 12-month revenue of around USD$5.1 billion.

How to buy shares in The Chemours Company

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for The Chemours Company. Find the stock by name or ticker symbol: CC. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until The Chemours Company reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of The Chemours Company, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of The Chemours Company. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

The Chemours Company share price

Use our graph to track the performance of CC stocks over time.

The Chemours Company shares at a glance

• Key figures

Information last updated 2020-10-20.

52-week range	USD$7.02 - USD$23.92
50-day moving average	USD$21.4751
200-day moving average	USD$16.7399
Wall St. target price	USD$20.36
PE ratio	6.547
Dividend yield	USD$1 (4.41%)
Earnings per share (TTM)	USD$2.395

Buy The Chemours Company shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Is it a good time to buy The Chemours Company stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of The Chemours Company by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is The Chemours Company under- or over-valued?

Valuing The Chemours Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of The Chemours Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

The Chemours Company's P/E ratio

The Chemours Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 7x. In other words, The Chemours Company shares trade at around 7x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

The Chemours Company's PEG ratio

The Chemours Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 8.75. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into The Chemours Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

The Chemours Company's EBITDA

The Chemours Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$278 million.

The EBITDA is a measure of a The Chemours Company's overall financial performance and is widely used to measure a its profitability.

The Chemours Company financials

Revenue TTM	USD$5.1 billion
Operating margin TTM	0.08%
Gross profit TTM	USD$1.1 billion
Return on assets TTM	0.04%
Return on equity TTM	-15.73%
Profit margin	-2.28%
Book value	$4
Market capitalisation	USD$3.7 billion

TTM: trailing 12 months

Shorting The Chemours Company shares

There are currently 12.1 million The Chemours Company shares held short by investors – that's known as The Chemours Company's "short interest". This figure is 5.5% down from 12.8 million last month.

There are a few different ways that this level of interest in shorting The Chemours Company shares can be evaluated.

The Chemours Company's "short interest ratio" (SIR)

The Chemours Company's "short interest ratio" (SIR) is the quantity of The Chemours Company shares currently shorted divided by the average quantity of The Chemours Company shares traded daily (recently around 1.4 million). The Chemours Company's SIR currently stands at 8.9. In other words for every 100,000 The Chemours Company shares traded daily on the market, roughly 8900 shares are currently held short.

However The Chemours Company's short interest can also be evaluated against the total number of The Chemours Company shares, or, against the total number of tradable The Chemours Company shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case The Chemours Company's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 The Chemours Company shares in existence, roughly 70 shares are currently held short) or 0.0869% of the tradable shares (for every 100,000 tradable The Chemours Company shares, roughly 87 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against The Chemours Company.

Find out more about how you can short The Chemours Company stock.

The Chemours Company share dividends

Dividend payout ratio: 49.02% of net profits

Recently The Chemours Company has paid out, on average, around 49.02% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.41% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), The Chemours Company shareholders could enjoy a 4.41% return on their shares, in the form of dividend payments. In The Chemours Company's case, that would currently equate to about $1 per share.

While The Chemours Company's payout ratio might seem fairly standard, it's worth remembering that The Chemours Company may be investing much of the rest of its net profits in future growth.

The Chemours Company's most recent dividend payout was on 15 September 2020. The latest dividend was paid out to all shareholders who bought their shares by 14 August 2020 (the "ex-dividend date").

The Chemours Company share price volatility

Over the last 12 months, The Chemours Company's shares have ranged in value from as little as $7.02 up to $23.92. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while The Chemours Company's is 2.3144. This would suggest that The Chemours Company's shares are significantly more volatile than the average for this exchange and represent a higher risk.

The Chemours Company overview

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Fluoroproducts, Chemical Solutions, and Titanium Technologies. The Fluoroproducts segment offers fluorochemicals, including refrigerants, foam blowing agents, and propellants under the Freon and Opteon brand names; fluoropolymers, such as industrial resins, specialty products, and coatings under the Teflon, Viton, Krytox, and Nafion brands; and fluoroelastomer products under the Viton brand name for electronics, communications, automotive, wire and cable, energy, oil and gas, aerospace, and other applications. The Chemical Solutions segment provides industrial and specialty chemicals for gold production, consumer, plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining industries. The Titanium Technologies segment manufactures and sells titanium dioxide pigments under the Ti-Pure and BaiMax brands for applications in architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers, and coated papers and paperboards used for packaging. It sell its products through direct channels, as well as through a network of resellers and distributors. The Chemours Company was founded in 2014 and is headquartered in Wilmington, Delaware.

Frequently asked questions

• What percentage of The Chemours Company is owned by insiders or institutions?

  Currently 0.958% of The Chemours Company shares are held by insiders and 82.287% by institutions.

• How many people work for The Chemours Company?

  Latest data suggests 7,000 work at The Chemours Company.

• When does the fiscal year end for The Chemours Company?

  The Chemours Company's fiscal year ends in December.

• Where is The Chemours Company based?

  The Chemours Company's address is: 1007 Market Street, Wilmington, DE, United States, 19801

• What is The Chemours Company's ISIN number?

  The Chemours Company's international securities identification number is: US1638511089

• What is The Chemours Company's CUSIP number?

  The Chemours Company's Committee on Uniform Securities Identification Procedures number is: 163851108